Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
AI in neuro-oncology: current advances and legal considerations in the European Union
0
Zitationen
6
Autoren
2026
Jahr
Abstract
Abstract Applications utilizing artificial intelligence (AI) have become a ubiquitous, indispensable part of modern life. This also applies to medicine where AI systems can support staff in decision-making processes and administrative tasks, but there is still uncertainty about the legality of their use. This review introduces examples from neuro-oncology, highlighting legal aspects and providing suggestions for the application of the Medical Device Regulation, the European Regulation on Artificial Intelligence (AI Act), the General Data Protection Regulation, and potential liability issues. AI systems for medical use are medical devices and high-risk AI systems that require the necessary certifications and entail strict requirements for clinical use. Since this may also apply to general AI tools if they are used for medical purposes other than their intended use cases, such use must be critically examined. However, the ultimate responsibility for using AI systems in a medical setting lies with the physicians, who need to be appropriately trained and made aware of the rules and regulations.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.578 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.470 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.984 Zit.
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
2019 · 6.814 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.